BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24926819)

  • 1. Increased risk of developing cutaneous malignant melanoma is associated with variation in pigmentation genes and VDR, and may involve epistatic effects.
    Kosiniak-Kamysz A; Marczakiewicz-Lustig A; Marcińska M; Skowron M; Wojas-Pelc A; Pośpiech E; Branicki W
    Melanoma Res; 2014 Aug; 24(4):388-96. PubMed ID: 24926819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple pigmentation gene polymorphisms account for a substantial proportion of risk of cutaneous malignant melanoma.
    Duffy DL; Zhao ZZ; Sturm RA; Hayward NK; Martin NG; Montgomery GW
    J Invest Dermatol; 2010 Feb; 130(2):520-8. PubMed ID: 19710684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of pigmentation and melanoma predisposition.
    Pho LN; Leachman SA
    G Ital Dermatol Venereol; 2010 Feb; 145(1):37-45. PubMed ID: 20197744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of the VDR gene are associated with presence of solar keratoses on the skin.
    Carless MA; Kraska T; Lintell N; Neale RE; Green AC; Griffiths LR
    Br J Dermatol; 2008 Sep; 159(4):804-10. PubMed ID: 18647306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study.
    Fargnoli MC; Altobelli E; Keller G; Chimenti S; Höfler H; Peris K
    Melanoma Res; 2006 Apr; 16(2):175-82. PubMed ID: 16567973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
    Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
    J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variants of the MATP/SLC45A2 gene are protective for melanoma in the French population.
    Guedj M; Bourillon A; Combadières C; Rodero M; Dieudé P; Descamps V; Dupin N; Wolkenstein P; Aegerter P; Lebbe C; Basset-Seguin N; Prum B; Saiag P; Grandchamp B; Soufir N;
    Hum Mutat; 2008 Sep; 29(9):1154-60. PubMed ID: 18683857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants.
    Stefanaki I; Stratigos AJ; Dimisianos G; Nikolaou V; Papadopoulos O; Polydorou D; Gogas H; Tsoutsos D; Panagiotou P; Kanavakis E; Antoniou C; Katsambas AD
    Br J Dermatol; 2007 Feb; 156(2):357-62. PubMed ID: 17223878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contribution of melanocortin 1 receptor gene polymorphisms and the agouti signalling protein gene 8818A>G polymorphism to cutaneous melanoma and basal cell carcinoma in a Polish population.
    Brudnik U; Branicki W; Wojas-Pelc A; Kanas P
    Exp Dermatol; 2009 Feb; 18(2):167-74. PubMed ID: 18637131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians.
    Nan H; Kraft P; Hunter DJ; Han J
    Int J Cancer; 2009 Aug; 125(4):909-17. PubMed ID: 19384953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allele variations in the OCA2 gene (pink-eyed-dilution locus) are associated with genetic susceptibility to melanoma.
    Jannot AS; Meziani R; Bertrand G; Gérard B; Descamps V; Archimbaud A; Picard C; Ollivaud L; Basset-Seguin N; Kerob D; Lanternier G; Lebbe C; Saiag P; Crickx B; Clerget-Darpoux F; Grandchamp B; Soufir N; Melan-Cohort
    Eur J Hum Genet; 2005 Aug; 13(8):913-20. PubMed ID: 15889046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic analysis of three important genes in pigmentation and melanoma susceptibility: CDKN2A, MC1R and HERC2/OCA2.
    Ibarrola-Villava M; Fernandez LP; Pita G; Bravo J; Floristan U; Sendagorta E; Feito M; Avilés JA; Martin-Gonzalez M; Lázaro P; Benítez J; Ribas G
    Exp Dermatol; 2010 Sep; 19(9):836-44. PubMed ID: 20629734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential association of single nucleotide polymorphisms in pigmentation genes with the development of basal cell carcinoma.
    Kosiniak-Kamysz A; Pośpiech E; Wojas-Pelc A; Marcińska M; Branicki W
    J Dermatol; 2012 Aug; 39(8):693-8. PubMed ID: 22512251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population.
    Stratigos AJ; Dimisianos G; Nikolaou V; Poulou M; Sypsa V; Stefanaki I; Papadopoulos O; Polydorou D; Plaka M; Christofidou E; Gogas H; Tsoutsos D; Kastana O; Antoniou C; Hatzakis A; Kanavakis E; Katsambas AD
    J Invest Dermatol; 2006 Aug; 126(8):1842-9. PubMed ID: 16601669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations.
    Yang XR; Liang X; Pfeiffer RM; Wheeler W; Maeder D; Burdette L; Yeager M; Chanock S; Tucker MA; Goldstein AM
    Fam Cancer; 2010 Dec; 9(4):625-33. PubMed ID: 20574843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma.
    Hutchinson PE; Osborne JE; Lear JT; Smith AG; Bowers PW; Morris PN; Jones PW; York C; Strange RC; Fryer AA
    Clin Cancer Res; 2000 Feb; 6(2):498-504. PubMed ID: 10690530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MC1R gene variants and sporadic malignant melanoma susceptibility in the Canary Islands population.
    Córdoba-Lanús E; Hernández-Jiménez JG; Medina-Coello C; Espinoza-Jiménez A; González A; Rodríguez-Pérez MD; Carretero-Hernández G; Almeida P; Suárez-Hernández J; Perera-Molinero A; Fernández-de-Misa R
    Arch Dermatol Res; 2014 Jan; 306(1):51-8. PubMed ID: 24170137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline melanoma susceptibility and prognostic genes: a review of the literature.
    Ward KA; Lazovich D; Hordinsky MK
    J Am Acad Dermatol; 2012 Nov; 67(5):1055-67. PubMed ID: 22583682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin pigmentation polymorphisms associated with increased risk of melanoma in a case-control sample from southern Brazil.
    Reis LB; Bakos RM; Vianna FSL; Macedo GS; Jacovas VC; Ribeiro-Dos-Santos AM; Santos S; Bakos L; Ashton-Prolla P
    BMC Cancer; 2020 Nov; 20(1):1069. PubMed ID: 33167923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pigmentation-related genes and their implication in malignant melanoma susceptibility.
    Fernandez LP; Milne RL; Pita G; Floristan U; Sendagorta E; Feito M; Avilés JA; Martin-Gonzalez M; Lázaro P; Benítez J; Ribas G
    Exp Dermatol; 2009 Jul; 18(7):634-42. PubMed ID: 19320733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.